Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Dalgleish

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
American Journal of Surgery|July 22, 2008
Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumorsCharles Evans, Christine Galustian, Devinder Kumar, et al.
Translational Oncology|December 12, 2018
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell VaccineHayley Leeman, Elwira Kaminska, Deborah Green, et al.
Current HIV Research|November 30, 2016
Effect of the Modification of p24 Peptide Antigen on Dendritic Cell Uptake and T Cell ActivationPeter L Smith, Kirstie J Norgate, Eve Hegarty, et al.
Cancer Research|February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteinsJ Blake Marriott, Ian A Clarke, Anna Czajka, et al.
Microvascular Research|March 31, 2005
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitroKeith Dredge, Rebecca Horsfall, Simon P Robinson, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2005
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma modelMarie-Christine Labarthe, Nicole Halanek, Lindsay Birchall, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cellsChristine Galustian, Brendan Meyer, Marie-Christine Labarthe, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)Alberto Fusi, Sandra Collette, Antonia Busse, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
American Journal of Surgery|July 22, 2008
Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumorsCharles Evans, Christine Galustian, Devinder Kumar, et al.
Translational Oncology|December 12, 2018
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell VaccineHayley Leeman, Elwira Kaminska, Deborah Green, et al.
Current HIV Research|November 30, 2016
Effect of the Modification of p24 Peptide Antigen on Dendritic Cell Uptake and T Cell ActivationPeter L Smith, Kirstie J Norgate, Eve Hegarty, et al.
Cancer Research|February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteinsJ Blake Marriott, Ian A Clarke, Anna Czajka, et al.
Microvascular Research|March 31, 2005
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitroKeith Dredge, Rebecca Horsfall, Simon P Robinson, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2005
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma modelMarie-Christine Labarthe, Nicole Halanek, Lindsay Birchall, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cellsChristine Galustian, Brendan Meyer, Marie-Christine Labarthe, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)Alberto Fusi, Sandra Collette, Antonia Busse, et al.
Pageof 9